HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ka-Loh Li Selected Research

Neoplasms (Cancer)

10/2021The LEGATOS technique: A new tissue-validated dynamic contrast-enhanced MRI method for whole-brain, high-spatial resolution parametric mapping.
5/2020The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.
1/2019Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
1/2018Low-dose T1W DCE-MRI for early time points perfusion measurement in patients with intracranial tumors: A pilot study applying the microsphere model to measure absolute cerebral blood flow.
2/2016Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.
8/2012An improved coverage and spatial resolution--using dual injection dynamic contrast-enhanced (ICE-DICE) MRI: a novel dynamic contrast-enhanced technique for cerebral tumors.
7/2008Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.
12/2007Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
4/2007AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
10/2005Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ka-Loh Li Research Topics

Disease

10Neoplasms (Cancer)
10/2021 - 10/2005
4Acoustic Neuroma (Acoustic Neurinoma)
01/2021 - 01/2014
3Breast Neoplasms (Breast Cancer)
12/2007 - 10/2005
2Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2018 - 02/2016
1Inflammation (Inflammations)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Meningioma (Meningiomas)
01/2014
1Necrosis
10/2005

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
05/2020 - 04/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016 - 10/2005
2Phosphotransferases (Kinase)IBA
12/2007 - 04/2007
2Tyrosine Kinase InhibitorsIBA
12/2007 - 10/2005
2Tyrosine (L-Tyrosine)FDA Link
12/2007 - 04/2007
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2007 - 10/2005
2Axitinib (AG 013736)IBA
04/2007 - 10/2005
1Eosine Yellowish-(YS) (Eosin)IBA
10/2021
1Hematoxylin (Haematoxylon)IBA
10/2021
1PK 11195 (PK11195)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Fibrinogen (Factor I)FDA Link
01/2019
1Bevacizumab (Avastin)FDA Link
01/2018
1IceIBA
08/2012
1GadoliniumIBA
07/2008
1ErbB Receptors (EGF Receptor)IBA
12/2007
1Growth Factor ReceptorsIBA
12/2007
1Biological ProductsIBA
12/2007
1Gefitinib (Iressa)FDA Link
12/2007

Therapy/Procedure

5Therapeutics
01/2021 - 10/2005
1Microspheres (Microsphere)
01/2018
1Neoadjuvant Therapy
07/2008